Difference in treatment algorithms for hepatocellular carcinoma between world's principal guidelines

Area of Science:

• Hepatology
• Oncology
• Clinical Practice Guidelines

Background:

• Hepatocellular carcinoma (HCC) is a significant global health concern, ranking as the fifth most common cancer and the second leading cause of cancer-related mortality.
• Established clinical guidelines aim to standardize HCC management, but regional variations exist.

Purpose of the Study:

• To summarize and compare the treatment algorithms presented in updated Hepatocellular carcinoma (HCC) clinical guidelines from various international and regional bodies.
• To highlight variations in treatment strategies across different guidelines and understand the underlying reasons for these differences.

Main Methods:

• A comparative analysis of updated Hepatocellular carcinoma (HCC) treatment guidelines was performed.
• Guidelines from Japan, China, Hong Kong, the Asian-Pacific Association for the Study of the Liver, the American Association for the Study of Liver Diseases, and the European Association for the Study of the Liver and European Organization for Research and Treatment of Cancer were included.

Main Results:

• Significant variations in Hepatocellular carcinoma (HCC) treatment algorithms were identified across the compared guidelines.
• Differences are attributed to regional variations in HCC prevalence, etiology, clinical practices, and healthcare systems.

Conclusions:

• Understanding global guideline variations is crucial for Hepatocellular carcinoma (HCC) management.
• Comparative analysis can inform future revisions and potentially harmonize treatment strategies worldwide, aiding practitioners facing diverse patient populations.